Echocardiographic view and feature selection for the estimation of the response to CRT.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 31 03 2021
accepted: 25 05 2021
entrez: 10 6 2021
pubmed: 11 6 2021
medline: 12 11 2021
Statut: epublish

Résumé

Cardiac resynchronization therapy (CRT) is an implant-based therapy applied to patients with a specific heart failure (HF) profile. The identification of patients that may benefit from CRT is a challenging task and the application of current guidelines still induce a non-responder rate of about 30%. Several studies have shown that the assessment of left ventricular (LV) mechanics by speckle tracking echocardiography can provide useful information for CRT patient selection. A comprehensive evaluation of LV mechanics is normally performed using three different echocardioraphic views: 4, 3 or 2-chamber views. The aim of this study is to estimate the relative importance of strain-based features extracted from these three views, for the estimation of CRT response. Several features were extracted from the longitudinal strain curves of 130 patients and different methods of feature selection (out-of-bag random forest, wrapping and filtering) have been applied. Results show that more than 50% of the 20 most important features are calculated from the 4-chamber view. Although features from the 2- and 3-chamber views are less represented in the most important features, some of the former have been identified to provide complementary information. A thorough analysis and interpretation of the most informative features is also provided, as a first step towards the construction of a machine-learning chain for an improved selection of CRT candidates.

Identifiants

pubmed: 34111154
doi: 10.1371/journal.pone.0252857
pii: PONE-D-21-10579
pmc: PMC8191962
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0252857

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Minerva Cardioangiol. 2016 Oct;64(5):572-80
pubmed: 26099222
Circulation. 2011 Mar 15;123(10):1061-72
pubmed: 21357819
IEEE J Biomed Health Inform. 2015 Sep;19(5):1617-1626
pubmed: 25974958
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Eur J Heart Fail. 2019 Jan;21(1):74-85
pubmed: 30328654
PLoS One. 2019 Oct 3;14(10):e0222397
pubmed: 31581234
Eur Heart J. 2005 Jun;26(11):1094-100
pubmed: 15728648
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):1-11
pubmed: 25525063
JACC Cardiovasc Imaging. 2018 Mar;11(3):509-510
pubmed: 28734920
Europace. 2009 Nov;11 Suppl 5:v22-8
pubmed: 19861387
JACC Cardiovasc Imaging. 2019 Sep;12(9):1887-1888
pubmed: 31005538
J Am Soc Echocardiogr. 2018 Feb;31(2):220-230
pubmed: 29246513
Circulation. 2010 Nov 9;122(19):1910-8
pubmed: 20975000
Int J Cardiol. 2015 Apr 1;184:6-8
pubmed: 25705002
Circulation. 2008 May 20;117(20):2608-16
pubmed: 18458170
Am J Cardiol. 2003 Mar 15;91(6):684-8
pubmed: 12633798
Eur Heart J Cardiovasc Imaging. 2018 Sep 1;19(9):1010-1018
pubmed: 28954293
Circ Arrhythm Electrophysiol. 2018 Jan;11(1):e005499
pubmed: 29326129
Eur Heart J. 2004 Sep;25(18):1614-9
pubmed: 15351160
Int J Cardiol. 2016 Dec 15;225:402-407
pubmed: 27776243
Int J Cardiol. 2016 Jan 1;202:349-55
pubmed: 26426276
J Am Coll Cardiol. 2004 Nov 2;44(9):1834-40
pubmed: 15519016
J Am Soc Echocardiogr. 2015 Jun;28(6):700-8
pubmed: 25819341
Circ Arrhythm Electrophysiol. 2008 Jun 1;1(2):127-39
pubmed: 19808403
Eur J Heart Fail. 2020 Dec;22(12):2349-2369
pubmed: 33136300
JACC Cardiovasc Imaging. 2014 Oct;7(10):969-79
pubmed: 25240452
Circulation. 2008 Sep 9;118(11):1130-7
pubmed: 18725491
J Cardiovasc Electrophysiol. 2017 Apr;28(4):410-415
pubmed: 28176410
J Am Coll Cardiol. 2002 Nov 6;40(9):1615-22
pubmed: 12427414
Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):868-878
pubmed: 28950336
Circ Cardiovasc Imaging. 2016 Jun;9(6):
pubmed: 27252359
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1074-1077
pubmed: 30670601
Eur Heart J. 2010 Nov;31(21):2677-87
pubmed: 20801924
J Am Coll Cardiol. 2012 Apr 24;59(17):1509-18
pubmed: 22405632
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Circulation. 2011 Jan 4;123(1):70-8
pubmed: 21173353
J Am Coll Cardiol. 2015 Aug 11;66(6):631-41
pubmed: 26248989

Auteurs

Alban Gallard (A)

University of Rennes, CHU Rennes, Inserm, LTSI UMR 1099, Rennes, France.

Elena Galli (E)

University of Rennes, CHU Rennes, Inserm, LTSI UMR 1099, Rennes, France.

Arnaud Hubert (A)

University of Rennes, CHU Rennes, Inserm, LTSI UMR 1099, Rennes, France.

Auriane Bidaut (A)

University of Rennes, CHU Rennes, Inserm, LTSI UMR 1099, Rennes, France.

Virginie Le Rolle (V)

University of Rennes, CHU Rennes, Inserm, LTSI UMR 1099, Rennes, France.

Otto Smiseth (O)

Center for Cardiological Innovation and Department of Cardiology, Oslo University Hospital, Oslo, Norway.

Jens-Uwe Voigt (JU)

Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

Erwan Donal (E)

University of Rennes, CHU Rennes, Inserm, LTSI UMR 1099, Rennes, France.

Alfredo I Hernández (AI)

University of Rennes, CHU Rennes, Inserm, LTSI UMR 1099, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH